Skip to main content
Log in

Cost of Chronic Obstructive Pulmonary Disease in the Emergency Department and Hospital

An Analysis of Administrative Data from 218 US Hospitals

  • Original Research Article
  • Published:
Treatments in Respiratory Medicine

Abstract

Study objectives: Treatment of chronic obstructive pulmonary disease (COPD) in the emergency department (ED) or hospital accounts for a significant portion of COPD costs. This study estimates the cost of a COPD ED or hospitalization visit in the US.

Design: This observational study utilized administrative data from 218 acute care hospitals. ED/hospital discharges for COPD (International Classification of Diseases — Ninth Revision — Clinical Modification codes 491.xx. 492.xx, 496.xx) during 2001 were identified. Costs were determined for three groups: (i) ED only; (ii) standard admission; and (iii) severe admissions (intensive care unit [ICU] or intubation). Severe admissions were stratified into: (i) ICU/no intubation; (ii) intubation/no ICU; and (iii) ICU + intubation. Mean total costs and length of stay (LOS) were calculated for each group.

Results: A total of 59 735 ED/hospital encounters were identified: 20 431 ED only, 33 210 standard admissions, and 6094 severe admissions (4456 ICU/no intubation, 496 intubation/no ICU, and 1142 ICU/intubation). ED visits had a mean cost of $US571 ± 507 (year 2001 value). Inpatient costs ranged from $US5997 (± 5752) for a standard admission to $US36 743 (± 62 886) for ICU plus intubation admissions, while LOS ranged from 5.1 days (±4.5) to 14.8 days (± 16.7), respectively. In addition, only 10% of encounters required an intubation/ICU admission, but these accounted for 34% of the cost.

Conclusion: Cost of a COPD hospitalization is substantial in the US, with one-third of those costs being associated with severe admissions, which make up only 10% of all COPD admissions. Treatments aimed at reducing hospitalizations and length of stay could result in substantial cost savings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Fig. 1
Table II
Table III
Table IV
Table V

Similar content being viewed by others

References

  1. Murphy SL. Deaths: final data for 1998. Natl Vital S tat Rep 2000; 48: 1–105

    CAS  Google Scholar 

  2. National Institutes of Health. 2004 Chart Book. Bethesda (MD): National Heart, Lung and Blood institute (NHLBI), 2004

    Google Scholar 

  3. American Lung Association. Trends in chronic bronchitis and emphysema: morbidity and mortality 2003 [online]. Available from URL: http://www.lungusa.org/data/copd/copdl.pdf [Accessed 2003 Mar 1]

  4. Strassels SA, Smith DH, Sullivan SD, et al. The costs of treating COPD in the United States. Chest 2001; 119: 344–52

    Article  PubMed  CAS  Google Scholar 

  5. Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1608–13

    PubMed  CAS  Google Scholar 

  6. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418–22

    PubMed  CAS  Google Scholar 

  7. Connors Jr AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154: 959–67

    PubMed  Google Scholar 

  8. Mushlin AI, Black ER, Connolly CA, et al. The necessary length of hospital stay for chronic pulmonary disease. JAMA 1991; 266: 80–3

    Article  PubMed  CAS  Google Scholar 

  9. Afessa B, Morales IJ, Scanlon PD, et al. Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure. Crit Care Med 2002; 30: 1610–5

    Article  PubMed  Google Scholar 

  10. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83

    Article  PubMed  CAS  Google Scholar 

  11. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993; 46: 1075–9

    Article  PubMed  CAS  Google Scholar 

  12. Center for Medicare and Medicaid Services. Prospective payment system payment impact file (May 2001 Update) [online]. Available from URL: http://cms.hhs.gov/providers/pufdownload/defaultasp [Accessed 2002 Jul 25]

  13. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 1983; 78: 605–10

    Article  Google Scholar 

  14. SAS Institute. SAS Procedures Guide, Version 8. 2. Cary (NC): SAS Institute, 2002

    Google Scholar 

  15. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. Respir Care 2002; 47: 1184–99

    PubMed  Google Scholar 

  16. Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58:100–5

    Article  PubMed  CAS  Google Scholar 

  17. Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project Page [online]. Available from URL: http://www.ahrq.gov/data/hcup/hcupnet.htm [Accessed 2003 Mar 1]

Download references

Acknowledgments

This research was funded by GlaxoSmithKline. RH Stanford is an employee at GlaxoSmithKline.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard H. Stanford.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stanford, R.H., Shen, Y. & McLaughlin, T. Cost of Chronic Obstructive Pulmonary Disease in the Emergency Department and Hospital. Treat Respir Med 5, 343–349 (2006). https://doi.org/10.2165/00151829-200605050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151829-200605050-00005

Keywords

Navigation